Podolski Joseph

Avg. Two Year Performance

47% Avg. Purchase Return

21% Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	(2%)	24%	16%	2%	47%
Purchase Success Rate	8 of 20	13 of 20	10 of 20	12 of 20	8 of 20
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

Repros Therapeutics Inc.

Other » Other

President and CEO, Director:

Holdings: 107.42K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--